Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7795924
[patent_doc_number] => 08124630
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-28
[patent_title] => 'ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 09/993647
[patent_app_country] => US
[patent_app_date] => 2001-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26848
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/124/08124630.pdf
[firstpage_image] =>[orig_patent_app_number] => 09993647
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/993647 | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | Nov 26, 2001 | Issued |
Array
(
[id] => 7225409
[patent_doc_number] => 20040072853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Therapeutic compounds'
[patent_app_type] => new
[patent_app_number] => 10/433884
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30381
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 29
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072853.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433884
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433884 | Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds | Nov 25, 2001 | Issued |
Array
(
[id] => 544882
[patent_doc_number] => 07163940
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-16
[patent_title] => 'Pyrazolopyridinyl pyrimidine therapeutic compounds'
[patent_app_type] => utility
[patent_app_number] => 10/433881
[patent_app_country] => US
[patent_app_date] => 2001-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42251
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/163/07163940.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433881
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433881 | Pyrazolopyridinyl pyrimidine therapeutic compounds | Nov 25, 2001 | Issued |
Array
(
[id] => 7386551
[patent_doc_number] => 20040082586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'Delta 1-pyrrolines used as pesticides'
[patent_app_type] => new
[patent_app_number] => 10/433443
[patent_app_country] => US
[patent_app_date] => 2003-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24179
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20040082586.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433443
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433443 | Δ1-pyrrolines used as pesticides | Nov 21, 2001 | Issued |
Array
(
[id] => 1378166
[patent_doc_number] => 06559150
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-05-06
[patent_title] => 'Growth hormone secretagogues'
[patent_app_type] => B2
[patent_app_number] => 09/989040
[patent_app_country] => US
[patent_app_date] => 2001-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31787
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 2145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/559/06559150.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989040
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989040 | Growth hormone secretagogues | Nov 20, 2001 | Issued |
Array
(
[id] => 6546006
[patent_doc_number] => 20020137755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Tyrosine kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/990473
[patent_app_country] => US
[patent_app_date] => 2001-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34802
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137755.pdf
[firstpage_image] =>[orig_patent_app_number] => 09990473
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/990473 | Tyrosine kinase inhibitors | Nov 20, 2001 | Abandoned |
Array
(
[id] => 6660204
[patent_doc_number] => 20030134848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholin receptors activators'
[patent_app_type] => new
[patent_app_number] => 10/009607
[patent_app_country] => US
[patent_app_date] => 2001-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11228
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134848.pdf
[firstpage_image] =>[orig_patent_app_number] => 10009607
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/009607 | Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholin receptors activators | Nov 20, 2001 | Abandoned |
Array
(
[id] => 7625446
[patent_doc_number] => 06723723
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-20
[patent_title] => 'Heterocyclic derivatives as inhibitors of factor Xa'
[patent_app_type] => B1
[patent_app_number] => 09/913071
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6618
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/723/06723723.pdf
[firstpage_image] =>[orig_patent_app_number] => 09913071
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/913071 | Heterocyclic derivatives as inhibitors of factor Xa | Nov 14, 2001 | Issued |
Array
(
[id] => 6274609
[patent_doc_number] => 20020106338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Galenical formulation'
[patent_app_type] => new
[patent_app_number] => 09/987439
[patent_app_country] => US
[patent_app_date] => 2001-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9751
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20020106338.pdf
[firstpage_image] =>[orig_patent_app_number] => 09987439
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/987439 | Galenical formulation | Nov 13, 2001 | Abandoned |
Array
(
[id] => 7605330
[patent_doc_number] => 07115599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-03
[patent_title] => 'Sulfonamide-substituted pyrazolopyridine compounds'
[patent_app_type] => utility
[patent_app_number] => 10/432572
[patent_app_country] => US
[patent_app_date] => 2001-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8953
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115599.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432572
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432572 | Sulfonamide-substituted pyrazolopyridine compounds | Nov 11, 2001 | Issued |
Array
(
[id] => 1528375
[patent_doc_number] => 06479498
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Sodium channel drugs and uses'
[patent_app_type] => B1
[patent_app_number] => 10/039699
[patent_app_country] => US
[patent_app_date] => 2001-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 27
[patent_no_of_words] => 58669
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479498.pdf
[firstpage_image] =>[orig_patent_app_number] => 10039699
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/039699 | Sodium channel drugs and uses | Nov 8, 2001 | Issued |
Array
(
[id] => 7612746
[patent_doc_number] => 06903089
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-06-07
[patent_title] => 'Lactam-substituted pyrazolopyridine derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/432740
[patent_app_country] => US
[patent_app_date] => 2001-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9404
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/903/06903089.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432740
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432740 | Lactam-substituted pyrazolopyridine derivatives | Nov 8, 2001 | Issued |
Array
(
[id] => 658393
[patent_doc_number] => 07105523
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-12
[patent_title] => 'Carbamate-substituted pyrazolopyridine-derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/432571
[patent_app_country] => US
[patent_app_date] => 2001-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9475
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/105/07105523.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432571
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432571 | Carbamate-substituted pyrazolopyridine-derivatives | Nov 8, 2001 | Issued |
Array
(
[id] => 6112821
[patent_doc_number] => 20020173514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-21
[patent_title] => 'Pyridine-substituted pyrazolopyridine derivatives'
[patent_app_type] => new
[patent_app_number] => 10/001569
[patent_app_country] => US
[patent_app_date] => 2001-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5554
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20020173514.pdf
[firstpage_image] =>[orig_patent_app_number] => 10001569
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/001569 | Pyridine-substituted pyrazolopyridine derivatives | Oct 31, 2001 | Issued |
Array
(
[id] => 5845399
[patent_doc_number] => 20020132822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Pyrimidine-2,4,6-trione metalloproteinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/032837
[patent_app_country] => US
[patent_app_date] => 2001-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24282
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132822.pdf
[firstpage_image] =>[orig_patent_app_number] => 10032837
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/032837 | Pyrimidine-2,4,6-trione metalloproteinase inhibitors | Oct 24, 2001 | Issued |
Array
(
[id] => 6112825
[patent_doc_number] => 20020173515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-21
[patent_title] => 'Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds'
[patent_app_type] => new
[patent_app_number] => 10/047935
[patent_app_country] => US
[patent_app_date] => 2001-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21388
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20020173515.pdf
[firstpage_image] =>[orig_patent_app_number] => 10047935
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/047935 | Antiproliferative substituted 5-thiapyrimidinone and 5-selenopyrimidinone compounds | Oct 22, 2001 | Abandoned |
Array
(
[id] => 5874830
[patent_doc_number] => 20020049220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Substituted azoles'
[patent_app_type] => new
[patent_app_number] => 09/975913
[patent_app_country] => US
[patent_app_date] => 2001-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22244
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049220.pdf
[firstpage_image] =>[orig_patent_app_number] => 09975913
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/975913 | Substituted azoles | Oct 11, 2001 | Issued |
Array
(
[id] => 5908113
[patent_doc_number] => 20020142993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'Pharmaceutically acceptable salts of bicyclic compounds'
[patent_app_type] => new
[patent_app_number] => 09/975741
[patent_app_country] => US
[patent_app_date] => 2001-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10765
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20020142993.pdf
[firstpage_image] =>[orig_patent_app_number] => 09975741
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/975741 | Pharmaceutically acceptable salts of bicyclic compounds | Oct 9, 2001 | Abandoned |
Array
(
[id] => 1062967
[patent_doc_number] => 06849625
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-01
[patent_title] => 'Quinazoline derivatives with anti-tumour activity'
[patent_app_type] => utility
[patent_app_number] => 10/398793
[patent_app_country] => US
[patent_app_date] => 2001-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31247
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/849/06849625.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398793
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398793 | Quinazoline derivatives with anti-tumour activity | Oct 8, 2001 | Issued |
Array
(
[id] => 1383292
[patent_doc_number] => 06555684
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-04-29
[patent_title] => 'Pyrimidinyl compounds for treatment of central nervous system disorders'
[patent_app_type] => B2
[patent_app_number] => 09/973419
[patent_app_country] => US
[patent_app_date] => 2001-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12627
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/555/06555684.pdf
[firstpage_image] =>[orig_patent_app_number] => 09973419
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/973419 | Pyrimidinyl compounds for treatment of central nervous system disorders | Oct 8, 2001 | Issued |